Insiders · Profile

Oltmans Curtis Gale

Chief Legal Officer at Fulcrum Therapeutics. Filing since 28 Jun 2021. CIK 0001714982

Company
Date
Role
Action
Shares
Amount
Of holding
15 Dec 2025
Chief Legal Officer
Sold at will
3,452
$44.60K
25.2%
28 Jun 2021
SVP, General Counsel
Bought
1,088
$9.80K
opened
2 decisions on file.